Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.41 |
| ▸ | MAPT | P10636 | 7/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.41 |
| ▸ | NPC1 | O15118 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.41 |
| ▸ | RELA | Q04206 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | APP | P05067 | 6/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22736381 | 0.97 | RAB9A (0.41) | RAB9AMAPTKDM4ESMN1; SMN2NPC1 | |
| SCHEMBL22178280 | 0.97 | ALOX5 (0.42) | RAB9AMAPTKDM4ESMN1; SMN2NPC1 | |
| SCHEMBL22736613 | 0.96 | RAB9A (0.40) | RAB9AMAPTKDM4ESMN1; SMN2NPC1 | |
| SCHEMBL22178183 | 0.95 | APP (0.42) | RAB9AMAPTKDM4ESMN1; SMN2NPC1 | |
| SCHEMBL22177834 | 0.94 | APP (0.42) | RAB9AMAPTKDM4ESMN1; SMN2NPC1 | |
| SCHEMBL22177637 | 0.94 | RAB9A (0.44) | RAB9AMAPTKDM4ESMN1; SMN2NPC1 | |
| SCHEMBL22178088 | 0.93 | RAB9A (0.39) | RAB9AMAPTKDM4ESMN1; SMN2NPC1 | |
| SCHEMBL22736379 | 0.93 | ALOX5 (0.45) | RAB9AMAPTKDM4ESMN1; SMN2NPC1 | |
| SCHEMBL22177856 | 0.93 | RAB9A (0.45) | RAB9AMAPTKDM4ESMN1; SMN2NPC1 | |
| SCHEMBL22178204 | 0.93 | RAB9A (0.45) | RAB9AMAPTKDM4ESMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11518769-B2 | Heterocyclic compounds and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2022-12-06 | — | — | US | disclosed |
| US-20200207754-A1 | NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200207754-A1 | NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CRY1, CRY2, CYP1A1 | RAB9A 2411/4885MAPT 1997/4885KDM4E 2374/4885 |
| US-11518769-B2 | Heterocyclic compounds and organic light emitting device using the same | CRY1, CYP1A1, CRY2 | RAB9A 2545/4885MAPT 1660/4885KDM4E 3498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.